Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 20 Nasopharyngeal Carcinoma 8 Lung Neoplasms 7 Colorectal Neoplasms 4 Melanoma 3 Esophageal Squamous Cell Carcinoma 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Osteosarcoma 2 Nasopharyngeal Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell 2 Esophageal Neoplasms 2 Unresectable Non-small Cell Lung Cancer 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Radiation Injuries 1 Quality of Life 1 Pleural Effusion, Malignant 1 Non-squamous Non-small Cell Lung Cancer 1 Neuroblastoma 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Bone Neoplasms 1 Advanced Pancreatic Cancer 1

Interventions

Cisplatin 253 Radiotherapy 176 Cetuximab 145 pembrolizumab 120 Docetaxel 97 Fluorouracil 92 Carboplatin 80 Paclitaxel 77 Radiotherapy, Intensity-Modulated 69 Nivolumab 37 Radiation 30 Drug Therapy 30 Erlotinib Hydrochloride 26 Gemcitabine 25 Cyclophosphamide 22 Gefitinib 21 Surveys and Questionnaires 20 Standard of Care 20 Surgical Procedures, Operative 19 Pemetrexed 19 durvalumab 18 Magnetic Resonance Spectroscopy 17 Capecitabine 17 Radiosurgery 16 Celecoxib 16 atezolizumab 15 Filgrastim 15 Amifostine 15 130-nm albumin-bound paclitaxel 15 fludarabine 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Head and Neck Neoplasms × endostar protein × Clear all

NCT03989830 2020-10-23

SLICER

Peking University

Phase 2 Unknown

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡